BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27088951)

  • 1. Intralesional mumps, measles and rubella vaccine in the treatment of cutaneous warts.
    Saini P; Mittal A; Gupta LK; Khare AK; Mehta S
    Indian J Dermatol Venereol Leprol; 2016; 82(3):343-5. PubMed ID: 27088951
    [No Abstract]   [Full Text] [Related]  

  • 2. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
    Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
    Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.
    Ulschmid CM; Patel J; Pan AY; Liegl M; Holland KE
    Pediatr Dermatol; 2023; 40(6):1057-1059. PubMed ID: 37596908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mumps, Measles, and Rubella Vaccine for the Treatment of a Recalcitrant Subungual Wart.
    Morales-Raya C; Maroñas-Jiménez L; Aragón-Miguel R; Postigo-Llorente C
    Actas Dermosifiliogr; 2017 Dec; 108(10):966-968. PubMed ID: 28709617
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy using topical measles, mumps and rubella vaccine for treatment of verruca plana.
    Mohta A; Kushwaha RK; Gautam U; Jain SK
    Indian J Dermatol Venereol Leprol; 2021; 87(2):285-287. PubMed ID: 33769758
    [No Abstract]   [Full Text] [Related]  

  • 6. Two-year experience of using the measles, mumps and rubella vaccine as intralesional immunotherapy for warts.
    Na CH; Choi H; Song SH; Kim MS; Shin BS
    Clin Exp Dermatol; 2014 Jul; 39(5):583-9. PubMed ID: 24934912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children.
    Mohta A; Kushwaha RK; Gautam U; Sharma P; Nyati A; Jain SK
    Pediatr Dermatol; 2020 Sep; 37(5):853-859. PubMed ID: 32681688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
    Nofal A; El-Arab RE; Nasr M; Alakad R
    J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Intralesional
    Zayan H; Hosny AH; Mamdouh MM; Tawfik YM
    J Cutan Med Surg; 2024; 28(3):253-258. PubMed ID: 38497287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
    Nofal A; Nofal E; Yosef A; Nofal H
    Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of measles-mumps-rubella vaccine versus salicylic acid-lactic paint in the treatment of warts.
    Deshmukh AR; Nawale SS; Patil SS; Pawar SS
    Indian J Dermatol Venereol Leprol; 2020; 86(6):753. PubMed ID: 32167070
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy of anogenital warts with measles, mumps, and rubella vaccine.
    Kansal NK
    Dermatol Ther; 2020 Nov; 33(6):e13987. PubMed ID: 32638481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional measles-mumps-rubella is associated with a higher complete response in cutaneous warts: a systematic review and meta-analysis of randomized controlled trial including GRADE qualification.
    Vania R; Pranata R; Tan ST
    J Dermatolog Treat; 2021 Dec; 32(8):1010-1017. PubMed ID: 31985307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralesional immunotherapy of plantar warts: report of a new antigen combination.
    Gamil H; Elgharib I; Nofal A; Abd-Elaziz T
    J Am Acad Dermatol; 2010 Jul; 63(1):40-3. PubMed ID: 20462659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
    Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
    J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine.
    Nofal A; Nofal E
    J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1166-70. PubMed ID: 20202055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of autoimplantation therapy and intralesional injection of MMR vaccine in warts treatment.
    ElGhareeb MI
    Dermatol Ther; 2019 Nov; 32(6):e13135. PubMed ID: 31648401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional immunotherapy with Mycobacterium w vaccine in patients with multiple cutaneous warts: uncontrolled open study.
    Meena JK; Malhotra AK; Mathur DK; Mathur DC
    JAMA Dermatol; 2013 Feb; 149(2):237-9. PubMed ID: 23426493
    [No Abstract]   [Full Text] [Related]  

  • 19. Intralesional injection of Candida albicans antigen versus measles, mumps, and rubella vaccine for treatment of plantar warts.
    Rageh RM; Hewedy ES; Hegab DS
    Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):1-5. PubMed ID: 33765749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
    Rutnin S; Namasondhi A; Pomsoong C; Kositkuljorn C; Anuntrangsee T; Thadanipon K
    Dermatology; 2023; 239(1):109-115. PubMed ID: 36282051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.